Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5H1D

Crystal structure of C-terminal of RhoGDI2

5H1D の概要
エントリーDOI10.2210/pdb5h1d/pdb
分子名称Rho GDP-dissociation inhibitor 2 (2 entities in total)
機能のキーワードsignaling protein
由来する生物種Homo sapiens (Human)
細胞内の位置Cytoplasm, cytosol : P52566
タンパク質・核酸の鎖数1
化学式量合計16427.71
構造登録者
Liu, J. (登録日: 2016-10-08, 公開日: 2016-10-26, 最終更新日: 2023-11-08)
主引用文献Liu, J.,Gao, J.,Li, F.,Ma, R.,Wei, Q.,Wang, A.,Wu, J.,Ruan, K.
NMR characterization of weak interactions between RhoGDI2 and fragment screening hits.
Biochim. Biophys. Acta, 1861:3061-3070, 2017
Cited by
PubMed Abstract: The delineation of intrinsically weak interactions between novel targets and fragment screening hits has long limited the pace of hit-to-lead evolution. Rho guanine-nucleotide dissociation inhibitor 2 (RhoGDI2) is a novel target that lacks any chemical probes for the treatment of tumor metastasis.
PubMed: 27721047
DOI: 10.1016/j.bbagen.2016.10.003
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.494 Å)
構造検証レポート
Validation report summary of 5h1d
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon